Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial

<p>Abstract</p> <p>Background</p> <p>Late onset neonatal sepsis (LOS) with the mortality of 17 to 27% is still a serious disease. Meropenem is an antibiotic with wide antibacterial coverage. The advantage of it over standard of care could be its wider antibacterial cove...

Full description

Saved in:
Bibliographic Details
Main Authors: de Cabre Vincent, Esposito Susanna, Standing Joseph, Metsvaht Tuuli, Heath Paul T, Trafojer Ursula MT, Lutsar Irja, Oeser Clarissa, Aboulker Jean-Pierre
Format: Artigo
Language:Inglês
Published: BMC 2011-09-01
Series:Trials
Subjects:
randomised controlled trial
neonate
premature neonate
FP7
Online Access:http://www.trialsjournal.com/content/12/1/215
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items